Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Common Equity (2019 - 2026)

Clene (CLNN) posted Common Equity of -$24.8 million for Q2 2026, down 40.84% on a QoQ basis from -$17.6 million in Q4 2025, and down 189.79% year-over-year from $27.6 million in Q2 2025.

Analysis

Clene (CLNN) Common Equity (2019 - 2026) Analysis & Trends

Clene has reported Common Equity for 8 years, with the latest figure at -$24.8 million in Q2 2026.

  • On a quarterly basis, Common Equity fell 189.79% year-over-year to -$24.8 million in Q2 2026; TTM through Jun 2026 was -$24.8 million, a 189.79% decrease from a year earlier, with the FY2025 full-year figure at -$17.6 million, down 98.62% from the prior year.
  • Common Equity was -$24.8 million for Q2 2026 at Clene, down from -$17.6 million in the prior quarter.
  • The five-year high for Common Equity was $21.5 million in Q2 2023, with the low at -$24.8 million in Q2 2026.
  • Average Common Equity over 5 years is -$1.6 million, with a median of -$1.6 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2025: Common Equity jumped 3923.62% in 2023, then tumbled 1596.43% in 2025.
  • Over 5 years, Common Equity stood at $3.2 million in 2022, then surged by 313.65% to $13.4 million in 2023, then plunged by 166.15% to -$8.9 million in 2024, then sank by 98.62% to -$17.6 million in 2025, then sank by 40.84% to -$24.8 million in 2026.
  • The last three Common Equity figures came in at -$24.8 million (Q2 2026), -$17.6 million (Q4 2025), and -$12.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 84.97 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -5.94 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 106.07 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 41.95 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 85.49 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 80.86 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 2.61 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 6.34 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 6.40 Bn
10 Clene 45.69 Mn 45.69 Mn 54,000.00 -24.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.78 Mn
Dec 31, 2025 -17.59 Mn
Sep 30, 2025 -12.36 Mn
Jun 30, 2025 -8.55 Mn
Mar 31, 2025 -4.97 Mn
Dec 31, 2024 -8.86 Mn
Sep 30, 2024 -4.13 Mn
Jun 30, 2024 -504,000.00
Mar 31, 2024 4.26 Mn
Dec 31, 2023 13.39 Mn
Sep 30, 2023 21.40 Mn
Jun 30, 2023 21.53 Mn
Mar 31, 2023 -1.63 Mn
Dec 31, 2022 3.24 Mn
Sep 30, 2022 -9.32 Mn
Jun 30, 2022 -563,000.00
Mar 31, 2022 2.02 Mn
Dec 31, 2021 12.60 Mn
Sep 30, 2021 5.69 Mn
Jun 30, 2021 -25.93 Mn